A More Sustainable Path to Scale and Reliability

As oligonucleotide and peptide therapies advance toward larger patient populations, manufacturing processes must deliver not only scalability and reliability, but also improved sustainability. AJIPHASE™ addresses these challenges through highly efficient liquid-phase chemistry that enables large-scale production while reducing resource consumption.
Compared with traditional solid-phase synthesis, AJIPHASE™ reduces the consumption of solvents, reagents, and raw materials, helping to lower process mass intensity.